ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism
ZEB1抑制通过IL17RD依赖性机制使KRAS突变型癌症对MEK抑制剂更加敏感。
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.aaq1238
Peng, David H; Kundu, Samrat T; Fradette, Jared J; Diao, Lixia; Tong, Pan; Byers, Lauren A; Wang, Jing; Canales, Jaime Rodriguez; Villalobos, Pamela A; Mino, Barbara; Yang, Yanan; Minelli, Rosalba; Peoples, Michael D; Bristow, Christopher A; Heffernan, Timothy P; Carugo, Alessandro; Wistuba, Ignacio I; Gibbons, Don L